P01848 (TRAC_HUMAN) Homo sapiens (Human)
T cell receptor alpha chain constant UniProtKBInterProInteractive Modelling
140 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
137 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of a membrane protein(CS) |
Heteromer A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 2×C3S; | |||
| Cryo-EM structure of a membrane protein(WT) |
Heteromer A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 2×CLR; | |||
| Cryo-EM structure of a membrane protein(LL) |
Heteromer A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 1×CLR; | |||
| Structure of human T cell receptor-CD3 complex |
Heteromer A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963; | 100 | ||||
| The crystal structure of TCR DMF5 |
Heteromer | 98.9 | 1×LI; 1×GOL; | |||
| Crystal structure of JKA6 TCR |
Heteromer A0A075B6T6; A0A5B6; P01850; | 98.9 | ||||
| Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… |
Heteromer | 98.78 | 6×SO4; 1×PG4; 4×PGE; | |||
| Crystal structure of staphylococcal enterotoxin E in complex with a T cell receptor |
Heteromer A0A0B4J277; A0A5A3; A0A5B9; P12993; | 98.88 | 1×ZN; | |||
| Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances af… |
Heteromer P01850; P04439; P61769; P78358; | 98.9 | ||||
| Structure of mouse Va14Vb8.2NKT TCR-mouse CD1d-a-C-Galactosylceramide complex |
Heteromer P01850; P01887; P11609; | 98.88 | 1×NAG; 1×QUX; 2×NAG; | |||
| Crystal Structure of the DM1 TCR in complex with HLA-B*4405 and decamer EBV antigen |
Heteromer P01889; P03204; P61769; | 98.9 | ||||
| T cell receptor (TRAV22,TRBV7-9) structure |
Heteromer A0A0B4J277; A0A5A3; A0A5B9; | 98.89 | 1×GOL; | |||
| Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8 and Beta Chain-TRBV7-8 |
Heteromer A0A0B4J279; A0A5B9; | 98.86 | ||||
| A structural basis for immunodominant human T-cell receptor recognition. |
Heteromer P01850; P04439; P61769; | 100 | ||||
| Crystal Structure of clone18 TCR |
Heteromer P01850; | 98.89 | ||||
| High Affinity alpha24-beta17 T Cell Receptor for A2 HLA-Melanoma peptide complex |
Heteromer P01850; | 98.89 | 5×EDO; 1×GOL; 3×SO4; | |||
| Crystal structure of the 2B4 TCR |
Heteromer | 98.85 | ||||
| Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr… |
Heteromer P01850; P61769; Q3KSU1; Q8WLS4; | 98.89 | 11×GOL; 7×SO4; 1×MES; | |||
| Ternary crystal structure of the NKT TCR-CD1d-alpha-galactosylceramide analogue-OCH |
Heteromer P01850; P01887; P11609; | 98.88 | 3×NAG; 2×PEG; 1×NAG; 1×FEE; 1×D12; | |||
| Crystal structure of the 2B4 TCR in complex with MCC/I-Ek |
Heteromer P00039; P04224; P04230; | 98.81 | 2×NAG; 2×FUC; 7×PEG; 1×BMA; | |||
| Crystal structure of the 5F TCR in complex with HLA-DP4-Ply |
Heteromer P01850; P04440; P20036; Q04IN8; | 98.89 | 1×NAG; 2×NAG; 3×EDO; | |||
| Ternary crystal structure of the mouse NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide |
Heteromer P01850; P01887; P11609; | 98.88 | 2×NAG; 1×NAG; 1×4GH; 1×PEG; | |||
| Crystal structure of mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR |
Heteromer P01887; P11609; | 98.8 | 1×NAG; 2×NAG; 1×AGH; | |||
| Ternary crystal structure of the mouse NKT TCR-CD1d-C20:2 |
Heteromer P01850; P01887; P11609; | 98.88 | 3×NAG; 1×DB3; | |||
| Crystal structure of the RL42 TCR unliganded |
Heteromer | 98.89 | ||||
| Ternary crystal structure of the mouse NKT TCR-CD1d-alpha-glucosylceramide(C20:2) |
Heteromer P01850; P01887; P11609; | 98.88 | 2×NAG; 1×NAG; 1×DB6; | |||
| Ternary crystal structure of the mouse NKT TCR-CD1d-3'deoxy-alpha-galactosylceramide |
Heteromer P01850; P01887; P11609; | 98.86 | 3×NAG; 1×3GH; | |||
| Crystal structure of staphylococcal enterotoxin A F47A mutant in complex with a T cell receptor |
Heteromer A0A0B4J277; A0A5A3; A0A5B9; P0A0L2; | 98.86 | ||||
| Crystal structure of the RL42 TCR in complex with HLA-B8-FLR |
Heteromer P01889; P61769; Q3KST2; | 98.89 | ||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; A0A0K0K1A5; P01850; | 97.75 | ||||
| Immune Receptor |
Heteromer P01850; | 100 | ||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; A0A0K0K1A5; P01850; P04439; P61769; P78358; | 98.88 | ||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; A0A0K0K1A5; P01850; P04439; P61769; P78358; | 98.88 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01850; | 98.85 | ||||
| 1E6 TCR in complex with HLA-A02 carrying RQFGPDWIVA |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.88 | 15×EDO; 2×PG4; 4×SO4; 1×GOL; | |||
| Crystal structure of the complex between human T cell receptor and staphylococcal enterotoxin |
Heteromer P01850; P0A0M0; | 98.88 | 3×GOL; 1×NA; | |||
| BK6 TCR apo structure |
Heteromer P01850; | 98.81 | ||||
| Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin … |
Heteromer P01850; P01903; P01911; P0A0M0; Q03909; | 98.88 | 4×GOL; 1×NA; | |||
| Crystal Structure of CA5 TCR-HLA B*3505-LPEP complex |
Heteromer C5MK56; P01850; P61769; Q3KSS8; | 97.75 | 3×NA; 8×IOD; | |||
| The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… |
Heteromer P04439; P61769; | 98.88 | ||||
| Crystal structure of TK3 TCR-HLA-B*35:08-HPVG complex |
Heteromer C5MK56; P01850; P03211; P61769; | 98.88 | 2×CL; 3×NA; | |||
| Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… |
Heteromer A0A0B4J279; A0A5B9; P15813; P61769; | 98.88 | 2×NAG; 1×JLS; | |||
| The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex |
Heteromer P01850; P01889; P61769; Q3KST2; | 100 | ||||
| Crystal structure of TK3 TCR-HLA-B*35:01-HPVG-Q5 complex |
Heteromer C5MK56; P01850; P03211; P61769; | 98.88 | 3×SO4; | |||
| Crystal Structure of SB27 TCR in complex with HLA-B*3508-13mer peptide |
Heteromer P01850; P01889; P03206; P61769; | 98.88 | 7×IOD; | |||
| Crystal structure of TK3 TCR-HLA-B*35:08-HPVG-D5 complex |
Heteromer C5MK56; P01850; P61769; Q3KSS4; | 98.88 | ||||
| Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-F5L |
Heteromer A0A075B6N1; A0A087WT01; A0A5B9; P04439; P61769; | 100.0 | ||||
| The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indo… |
Heteromer P01850; P04439; P61769; | 100 | 5×SO4; 13×GOL; 1×3IB; | |||
| Crystal structure of the mCD1d/NC-aGC/iNKTCR ternary complex |
Heteromer A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609; | 98.86 | 1×NAG; 1×NAG; 1×48G; 1×NAG; | |||
| Structure of the HLA-E-VMAPRTLIL/KK50.4 TCR complex |
Heteromer P01850; P13747; P16780; P61769; | 98.88 | 5×IOD; | |||
| Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF a mimotope |
Heteromer P01850; P01889; P61769; | 100 | ||||
| The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide |
Heteromer P04439; P61769; | 98.88 | ||||
| The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide |
Heteromer P04439; P61769; | 100 | 7×GOL; 1×SO4; | |||
| Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY a self peptide from… |
Heteromer P01850; P01889; P61769; | 100 | ||||
| Recognition of Glycolipid Antigen by iNKT Cell TCR |
Heteromer A0A5B9; P01887; P11609; | 98.88 | 1×NAG; 1×NAG; 1×GSL; 1×NAG; | |||
| Crystal Structure of SB47 TCR-HLA B*3505-LPEP complex |
Heteromer C5MK56; P01850; P61769; Q3KSS8; | 98.88 | 1×NA; 2×MG; | |||
| Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity a… |
Heteromer A0A5B9; P04440; P20036; | 98.88 | 3×NAG; 1×NA; 1×0BE; | |||
| Recognition of a Glycolipid Antigen by the iNKT Cell TCR |
Heteromer A0A5B9; P01887; P11609; | 98.88 | 1×NAG; 1×NAG; 1×NAG; 1×1O2; | |||
| Structure of the mouse CD1d-SMC124-iNKT TCR complex |
Heteromer A0A5B9; P01887; P11609; | 98.88 | 1×NAG; 1×NAG; 1×NAG; 1×07P; 1×GOL; | |||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01850; P01903; P01911; P60174; | 98.88 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01850; P01903; P01911; P60174; | 98.88 | ||||
| Structure of the mouse CD1d-PyrC-alpha-GalCer-iNKT TCR complex |
Heteromer P01887; P11609; | 98.86 | 1×NAG; 1×NAG; 1×NAG; 1×1LA; | |||
| CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A |
Heteromer P04439; P61769; | 98.88 | ||||
| Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope |
Heteromer P04439; P61769; | 98.88 | 1×SO4; 1×CL; | |||
| STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A |
Heteromer P04439; P61769; | 100 | ||||
| The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPh… |
Heteromer P01850; P04439; P61769; | 100 | 4×GOL; | |||
| X-ray structure of the complex between staphylococcal enterotoxin B, T cell receptor and major hist… |
Heteromer A0A5B9; P01552; P01903; P01911; P03437; | 98.85 | ||||
| Crystal structure of the mCD1d/EF77/iNKTCR ternary complex |
Heteromer A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609; | 98.86 | 1×NAG; 2×NAG; 1×49Y; | |||
| T15-DQ8.5-glia-gamma1 complex |
Heteromer A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01909; P08079; | 98.88 | 1×NAG; 2×NAG; | |||
| Structure of the mouse CD1d-alpha-C-GalCer-iNKT TCR complex |
Heteromer A0A5B9; P01887; P11609; | 98.88 | 1×NAG; 2×NAG; 1×QUX; | |||
| The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… |
Heteromer A0A075B6T6; A0A1B0GXE1; K7N5M4; P04439; P61769; Q16655; | 98.78 | ||||
| Crystal Structure of DN6 TCR |
Heteromer A0A5B9; | 97.75 | 4×NAG; 6×CL; 4×GOL; | |||
| Crystal structure of the mCD1d/7DW8-5/iNKTCR ternary complex |
Heteromer A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609; | 98.86 | 3×NAG; 1×7DW; | |||
| Crystal Structure of SB27 TCR in complex with the 'restriction triad' mutant HLA-B*3508-13mer |
Heteromer A0A5B9; P01889; P03206; P61769; | 98.88 | 7×IOD; | |||
| Crystal structure of the mCD1d/GCK152/iNKTCR ternary complex |
Heteromer A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609; | 98.86 | 2×NAG; 1×NAG; 1×49X; | |||
| Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylcerami… |
Heteromer P15813; P61769; | 98.78 | 1×GCY; | |||
| Crystal structure of the mCD1d/GCK127/iNKTCR ternary complex |
Heteromer A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609; | 98.86 | 1×NAG; 1×NAG; 1×49M; | |||
| Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and … |
Heteromer P15813; P61769; | 98.88 | 1×NAG; 2×NAG; 1×AGH; | |||
| 1E6 TCR in complex with HLA-A02 carrying YQFGPDFPIA |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.86 | 3×SO4; 3×EDO; | |||
| A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… |
Heteromer A0A5B9; | 98.86 | 2×ACY; | |||
| A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… |
Heteromer A0A5B9; | 98.86 | ||||
| A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… |
Heteromer A0A5B9; | 98.86 | ||||
| CD1a ternary complex with lysophosphatidylcholine and BK6 TCR |
Heteromer P01850; P06126; P61769; | 98.86 | 2×NAG; 1×42H; | |||
| CD1a ternary complex with endogenous lipids and BK6 TCR |
Heteromer P01850; P06126; P61769; | 98.86 | 1×NAG; 1×OLA; | |||
| human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 |
Heteromer A0A075B6N1; P04439; P61769; Q16655; | 98.86 | 1×NA; | |||
| HLA Class I antigen |
Heteromer A0A0B4J279; A0A592; A0A5B9; P04439; P40967; P61769; | 98.85 | 10×EDO; 3×GOL; 8×SO4; | |||
| 1E6 TCR in complex with HLA-A02 carrying RQFGPDFPTI |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.85 | 30×EDO; 3×GOL; 5×SO4; | |||
| Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… |
Heteromer P01850; P04439; P61769; Q16655; | 98.85 | 2×EPE; 7×SO4; | |||
| 1E6 TCR in complex with HLA-A02 carrying MVW peptide |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.85 | 5×EDO; 5×SO4; 1×GOL; | |||
| HLA class I histocompatibility antigen |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.85 | 4×SO4; | |||
| Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-isoglobotrihexosylce… |
Heteromer P01887; P11609; | 98.7 | 1×NAG; 2×NAG; 1×LGN; | |||
| Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… |
Heteromer P01850; P04439; P61769; | 98.85 | 4×SO4; 2×GOL; | |||
| Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-galactosylceram… |
Heteromer P01887; P11609; | 98.78 | 1×NAG; 2×NAG; 1×GCY; 1×GOL; | |||
| The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… |
Heteromer P04439; P61769; Q16655; | 98.85 | ||||
| The M33 TCR p3M33l/H-2 Ld Complex |
Heteromer A0A5B9; P01738; P01897; P04213; | 98.84 | ||||
| Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-sulfatide |
Heteromer P01887; P11609; | 98.78 | 1×NAG; 1×NAG; 1×NAG; 1×CIS; | |||
| Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-globotrihexosylceram… |
Heteromer P01887; P11609; | 98.7 | 1×NAG; 2×NAG; 1×3GB; | |||
| Crystal structure of the B1 TCR in complex with HLA-DP4-Ply |
Heteromer P01850; P04440; P20036; Q04IN8; | 98.85 | 1×NAG; 2×NAG; | |||
| Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide,… |
Heteromer P01850; P01903; P01911; P03437; | 100.0 | 1×NAG; 2×NAG; | |||
| Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… |
Heteromer P01850; P04439; P61769; | 98.84 | 1×TAM; 11×SO4; | |||
| COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 |
Heteromer A0A0K0K1A5; A0A5B9; P04437; P04439; P14079; P61769; | 100.0 | ||||
| The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… |
Heteromer P04439; P61769; Q16655; | 98.84 | ||||
| 42F3 TCR pCPC5/H-2Ld Complex |
Heteromer A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897; | 98.82 | ||||
| CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE,… |
Heteromer P01850; P01903; P01911; P03437; | 100.0 | 2×NAG; | |||
| Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4 |
Heteromer A0A5B9; P01903; P01911; | 100.0 | ||||
| Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-lactosylceramide |
Heteromer P01887; P11609; | 98.67 | 1×NAG; 2×NAG; 1×3GD; | |||
| 42F3 TCR pCPA12/H-2Ld complex |
Heteromer A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897; | 98.81 | ||||
| 42F3 pCPB7/H-2Ld Complex |
Heteromer A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897; | 98.84 | ||||
| Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4 |
Heteromer A0A5B9; P01730; P01903; P01911; | 100.0 | ||||
| Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-G4E |
Heteromer A0A075B6N1; A0A087WT01; A0A5B9; P04439; P61769; | 98.82 | ||||
| Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor |
Heteromer P01850; P61769; Q16655; Q8WLS4; | 98.82 | 2×GOL; 2×SO4; | |||
| Crystal structure of 3A6 TCR bound to MBP/HLA-DR2a |
Heteromer P01850; P01903; P02686; Q30154; | 100.0 | ||||
| Bel602-DQ8.5-glia-gamma1 complex |
Heteromer A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01909; P08079; | 98.8 | 1×NAG; 1×CA; | |||
| 42F3 TCR pCPE3/H-2Ld complex |
Heteromer A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897; | 98.75 | ||||
| MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 |
Heteromer A0A0B4J279; A0A578; A0A5B9; P04439; P61769; Q8WZ42; | 98.78 | 1×GOL; 11×SO4; | |||
| Bel502-DQ8-glia-alpha1 complex |
Heteromer A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; L8E864; P18573; | 98.78 | 4×NAG; 4×CA; | |||
| 1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P04439; P61769; | 98.78 | ||||
| MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 |
Heteromer A0A0B4J279; A0A578; A0A5B9; P04439; P43357; P61769; | 98.77 | 7×SO4; | |||
| UL40:01 TCR in complex with HLA-E with a non-natural amino acid |
Heteromer A0A087WT03; A0A087X096; A0A0B4J200; A0A5B0; A0A5B9; P13747; P61769; | 98.75 | ||||
| Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… |
Heteromer P04439; P61769; P78358; | 98.73 | 9×SO4; 3×PGE; 1×7PE; 11×GOL; | |||
| 1E6 TCR in Complex with HLA-A0e carrying RQWGPDPAAV |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769; | 98.73 | 12×EDO; 3×GOL; 4×SO4; | |||
| Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Bin… |
Heteromer P04439; P61769; P78358; | 98.72 | 8×GOL; 1×MG; 5×SO4; 1×IPA; 1×EPE; | |||
| T cell receptor CO3 |
Heteromer A0A0C4DH28; A0A1B0GX56; P01850; | 98.72 | 1×EDO; 2×SO4; | |||
| Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T c… |
Heteromer P01850; | 98.72 | ||||
| Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T c… |
Heteromer P01850; | 98.72 | ||||
| Crystal Structure of clone42 TCR |
Heteromer P01850; | 98.7 | ||||
| Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances af… |
Heteromer P04439; P61769; P78358; | 98.7 | 1×NA; 4×GOL; | |||
| Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal bin… |
Heteromer P04439; P61769; P78358; | 98.7 | 6×SO4; 11×GOL; 1×CA; 1×MG; 1×EPE; | |||
| Crystal structure of staphylococcal enterotoxin E in complex with a T cell receptor |
Heteromer A0A0B4J277; A0A5A3; A0A5B9; P12993; | 98.7 | 1×ZN; 2×NA; | |||
| Crystal structure of ELS4 TCR bound to HLA-B*3501 presenting EBV peptide EPLPQGQLTAY at 1.7A |
Heteromer P01850; P01889; P03206; P61769; | 98.7 | ||||
| CD1a-dideoxymycobactin-gdTCR complex |
Heteromer A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769; | 98.7 | 2×EDO; 1×WGR; 1×SO4; | |||
| Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… |
Heteromer A0A0B4J271; A0A0K0K1A5; A0A5B9; P15813; P61769; | 98.7 | 2×NAG; 1×JLS; | |||
| Crystal structure of the B5 TCR in complex with HLA-DP4-Ply |
Heteromer P01850; P04440; P20036; Q04IN8; | 98.67 | 1×NAG; 1×EDO; 1×NAG; | |||
| CD1a-sulfatide-gdTCR complex |
Heteromer A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769; | 98.28 | 1×CIS; 6×EDO; 1×NAG; 1×PEG; 2×SO4; | |||
| CD1a-endo-gdTCR complex |
Heteromer A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769; | 94.44 | 1×PEG; 1×SO4; | |||
| T cell receptor delta 2 gamma 9 with TCRD TM domain chimera of TRAC |
Heteromer B7Z8K6; P04234; P07766; P09693; P0CF51; P20963; | 100 | ||||
| COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 |
Heteromer A0A075B6T6; A0A0K0K1A5; A0A5B9; P04439; P14079; P61769; | 100 | 2×EMC; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7phr.1.A | monomer | 0.65 | 100.00 | |||
| 6mf8.1.A | monomer | 0.55 | 86.67 | |||